Showing 1 - 10 of 13,911
Apinya Wipatayotin, Published on 16/05/2025
» Preventive vaccination is essential in reducing the severity of symptoms and limiting the spread of infectious diseases, especially as flu season approaches, according to medical experts from the Bangkok Dusit Medical Services (BDMS) group.
Bloomberg News, Published on 15/05/2025
» HONG KONG — Health authorities in densely populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, as a resurgent wave spreads through Asia.
Published on 15/05/2025
» A United States government laboratory in Maryland, which conducts research on deadly diseases such as ebola, has been closed following a safety breach caused by a dispute between two scientists.
Gary Boyle, Published on 14/05/2025
» Thais are being warned about a rise in Covid-19 infections following the deaths of six people last week.
News, Post Reporters, Published on 13/05/2025
» Thais are being warned about a rise in Covid-19 infections following the deaths of six people last week.
Apinya Wipatayotin, Published on 10/05/2025
» Public Health Minister Somsak Thepsutin has urged the public not to panic amid concerns over a resurgence of Covid-19 in Thailand, emphasising that the disease is now classified as endemic.
News, Apinya Wipatayotin, Published on 09/05/2025
» People are advised to continue to follow coronavirus and influenza prevention guidance as the virus is expected to spread more during the rainy season and following the opening of schools next week, according to Thailand's Department of Disease Control (DDC).
News, Post Reporters, Published on 06/05/2025
» The anthrax situation in the northeastern province of Mukdahan is improving, with no new cases reported as of yesterday, according to the Public Health Ministry.
Published on 30/04/2025
» BEIJING - China has restated its case that Covid-19 may have originated in the United States after the administration of US President Donald Trump blamed a lab leak in China.
Oped, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.